FASCIOSCAPULOHUMERAL MUSCULAR DYSTROPHY
Clinical trials for FASCIOSCAPULOHUMERAL MUSCULAR DYSTROPHY explained in plain language.
Never miss a new study
Get alerted when new FASCIOSCAPULOHUMERAL MUSCULAR DYSTROPHY trials appear
Sign up with your email to follow new studies for FASCIOSCAPULOHUMERAL MUSCULAR DYSTROPHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for FSHD: experimental drug AOC 1020 completes early testing
Disease control CompletedThis study tested a new medicine called AOC 1020 in 90 adults with facioscapulohumeral muscular dystrophy (FSHD), a genetic condition that causes muscle weakness. The goal was to check if the drug is safe and how the body processes it. Participants received either the drug or a p…
Matched conditions: FASCIOSCAPULOHUMERAL MUSCULAR DYSTROPHY
Phase: PHASE1, PHASE2 • Sponsor: Avidity Biosciences, Inc. • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
How much protein do FSHD patients really need? new study aims to find out
Knowledge-focused CompletedThis study looks at how much protein adults with facioscapulohumeral muscular dystrophy (FSHD) need each day to support muscle health. Researchers will test different amino acid intakes in 10 participants using a non-invasive technique. The goal is to improve dietary recommendati…
Matched conditions: FASCIOSCAPULOHUMERAL MUSCULAR DYSTROPHY
Phase: NA • Sponsor: McGill University • Aim: Knowledge-focused
Last updated Jul 11, 2026 00:00 UTC